EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE

The intrinsic clearances (CLint) of 50 neutral and basic marketed drugs were determined in fresh human hepatocytes and the data used to predict human in vivo hepatic metabolic clearance (CLmet). A statistically significant correlation between scaled CLmet and actual CLmet was observed (r2 = 0.48, p < 0.05), and for 73% of the drugs studied, scaled clearances were within 2-fold of the actual clearance. These data have shown that CLint data generated in human hepatocytes can be used to provide estimates of human hepatic CLmet for both phase I and phase II processes. In addition, the utility of commercial and in-house cryopreserved hepatocytes was assessed by comparing with data derived from fresh cells. A set of 14 drugs metabolized by the major human cytochromes P450 (P450s) (CYP1A2, 2C9, 2C19, 2D6, and 3A4) and uridine diphosphate glucuronosyltransferases (UGT1A1, 1A4, 1A9, and 2B7) have been used to characterize the activity of freshly isolated and cryopreserved human and dog hepatocytes. The cryopreserved human and dog cells retained on average 94% and 81%, respectively, of the CLint determined in fresh cells. Cryopreserved hepatocytes retain their full activity for more than 1 year in liquid N2 and are thus a flexible resource of hepatocytes for in vitro assays. In summary, this laboratory has successfully cryopreserved human and dog hepatocytes as assessed by the turnover of prototypic P450 and UGT substrates, and both fresh and cryopreserved human hepatocytes may be used for the prediction of human hepatic CLmet.

[1]  J B Houston,et al.  Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. , 1994, Biochemical pharmacology.

[2]  Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics. , 1994, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  R. Foti,et al.  Flavin-containing monooxygenase activity in hepatocytes and microsomes: in vitro characterization and in vivo scaling of benzydamine clearance. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[4]  D. Utesch,et al.  Metabolic activity of fresh and cryopreserved dog hepatocyte suspensions. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.

[5]  K. Pang,et al.  Retention of transporter activities in cryopreserved, isolated rat hepatocytes. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[6]  A. Dennison,et al.  Cryopreservation of hepatocytes: a review of current methods for banking , 2004, Cell and Tissue Banking.

[7]  R. Obach,et al.  Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[8]  J B Houston,et al.  Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. , 1997, Drug metabolism reviews.

[9]  Masato Chiba,et al.  Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[10]  R C Chou,et al.  Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. , 1997, Journal of pharmaceutical sciences.

[11]  A. Li,et al.  Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. , 1999, Chemico-biological interactions.

[12]  I Mahmood,et al.  The Pharmacokinetic Principles Behind Scaling from Preclinical Results to Phase I Protocols , 1999, Clinical pharmacokinetics.

[13]  R. Plumb,et al.  Application of a generic fast gradient liquid chromatography tandem mass spectrometry method for the analysis of cytochrome P450 probe substrates. , 1998, Rapid communications in mass spectrometry : RCM.

[14]  G R Wilkinson,et al.  Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. , 1977, The Journal of pharmacology and experimental therapeutics.

[15]  T Ishizaki,et al.  Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data. , 1997, Pharmacology & therapeutics.

[16]  Yau Yi Lau,et al.  Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[17]  D. Jaeck,et al.  The Use of Human Hepatocytes to Select Compounds Based on Their Expected Hepatic Extraction Ratios in Humans , 1997, Pharmaceutical Research.

[18]  F. Oesch,et al.  Cultures with cryopreserved hepatocytes: applicability for studies of enzyme induction. , 2000, Chemico-biological interactions.

[19]  R. Riley,et al.  Automated definition of the enzymology of drug oxidation by the major human drug metabolizing cytochrome P450s. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[20]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[21]  F. Oesch,et al.  Metabolic activity of fresh and cryopreserved cynomolgus monkey (Macaca fascicularis) hepatocytes , 2000, Xenobiotica; the fate of foreign compounds in biological systems.

[22]  B. Burchell,et al.  In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. , 2002, The Journal of pharmacology and experimental therapeutics.

[23]  B. Hoener,et al.  Predicting the hepatic clearance of xenobiotics in humans from in vitro data , 1994, Biopharmaceutics & drug disposition.

[24]  A. Galetin,et al.  Progress Towards Prediction of Human Pharmacokinetic Parameters from In Vitro Technologies , 2003, Drug metabolism reviews.

[25]  R. Obach,et al.  Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[26]  N. Hewitt,et al.  Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte cultures. , 2001, Drug metabolism and disposition: the biological fate of chemicals.

[27]  G. Granneman,et al.  Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions , 1997, Clinical pharmacokinetics.

[28]  T Lavé,et al.  Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. , 1999, Journal of medicinal chemistry.

[29]  R. Obach.  The importance of nonspecific binding in in vitro matrices, its impact on enzyme kinetic studies of drug metabolism reactions, and implications for in vitro-in vivo correlations. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[30]  J. Silva,et al.  Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes. , 1999, Chemico-biological interactions.

[31]  R J Riley,et al.  Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[32]  T Lavé,et al.  Prediction of Hepatic Metabolic Clearance , 2001, Clinical pharmacokinetics.

[33]  F. Oesch,et al.  Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspension. , 1999, Drug metabolism and disposition: the biological fate of chemicals.

[34]  M. Leider.  Goodman & Gilman's The Pharmacological Basis of Therapeutics , 1985 .

[35]  T Lavé,et al.  Prediction of Hepatic Metabolic Clearance Based on Interspecies Allometric Scaling Techniques and In Vitro-In Vivo Correlations , 1999, Clinical pharmacokinetics.

[36]  Albert P. Li.  Overview: hepatocytes and cryopreservation--a personal historical perspective. , 1999, Chemico-biological interactions.

[37]  Y. Ishii,et al.  A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[38]  Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes , 2003, Xenobiotica; the fate of foreign compounds in biological systems.

[39]  Scott L Cockroft,et al.  The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[40]  I Mahmood,et al.  Interspecies scaling of renally secreted drugs. , 1998, Life sciences.

[41]  D J Rance,et al.  The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.